US FDA orders post-market surveillance for metal-on-metal hips
This article was originally published in RAJ Devices
The US Food and Drug Administration has asked manufacturers of metal-on-metal hip implants to carry out post-market surveillance studies1. The FDA has issued a total of 145 orders for post-market studies to 21 manufacturers, who are now required to submit research protocols to the agency addressing specific safety issues relating to their devices.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.